1 asset in Sertoli-Leydig Cell Tumor
Therapeutic assets addressing Sertoli-Leydig Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Sertoli-Leydig Cell Tumor | Instituto do Cancer do Estado de São Paulo | P2 | CCC (53) |